Zylet Bausch & Lomb - Treatment for Inflammatory Ocular Conditions

Zylet is a corticosteroid and antibiotic combination for the treatment of steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of infection exists. Zylet will be available in the United States early in the first quarter of 2005.

Posted: December 2004

Related Articles:

Zylet (loteprednol and tobramycin) FDA Approval History

View comments

Hide
(web3)